Only 28% of eligible 18 and 19-year-olds have received first MenB vaccine dose
The UK Health Security Agency warns that time is running out for young people to receive their first dose of the MenB vaccine before the 31 December deadline.
Just 28.2% of 18 and 19-year-olds have received a first dose of the MenB vaccine, according to figures from the UK Health Security Agency. This includes 228,297 out of 809,957 people in that age group. The one-off, time-limited programme offers two doses of a vaccine that protects against most strains of MenB bacteria.
The deadline for receiving a first dose is 31 December 2026. For those who receive their first dose in time, a second dose will be available until 31 March 2027. Two doses, given at least 28 days apart, are needed for protection.
Eligible individuals include all those born between 1 September 2007 and 31 August 2008, as well as people under 25 who started university or residential further education for the first time this autumn. The UKHSA said freshers have a risk about seven times higher than their peers who did not go to university. Experts noted that shared accommodation, parties, and large social networks can aid the spread of the bacteria.
Dr Shamez Ladhani, a consultant epidemiologist at the UKHSA, said time was running out and urged eligible people to book an appointment. He advised not to leave it until the end of term or forget it amongst Christmas and other holiday festivities. Dr Eliza Gil, a clinical lecturer at the London School of Hygiene & Tropical Medicine, said the peak season for invasive MenB infection was typically December to March.
The programme follows an unprecedented outbreak of meningitis B in Kent earlier this year, alongside clusters in Dorset and Berkshire that caused three deaths and lifelong health consequences for some survivors.
Prof Andrew Pollard, director of the Oxford Vaccine Group, said it is worrying that uptake is so low. Henry Gregg, chief executive of the National Pharmacy Association, said further action is needed to promote the offer, including strong promotion by universities to those in residential accommodation.
Key facts
- Just 28.2% of 18 and 19-year-olds have received their first MenB vaccine dose.
- The deadline for the first dose is 31 December 2026.
- Second doses will be available until 31 March 2027.
Three perspectives
Neutral
The UK Health Security Agency is offering a one-off, time-limited MenB vaccination programme to 18 and 19-year-olds and certain university students.
Positive
The MenB vaccine is highly effective and can protect young people against life-threatening conditions including meningitis and sepsis.
Negative
Uptake of the vaccine is low, with only 28.2% of the main age cohort having received a first dose.
Your week in news, every Wednesday
The biggest stories of the week for your edition, in your inbox every Wednesday morning, your time. Free, and you can unsubscribe at any time.